Mfn2em3Gwd
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Mfn2em3Gwd |
| Name: |
mitofusin 2; endonuclease-mediated mutation 3, Gerald W Dorn |
| MGI ID: |
MGI:7563991 |
| Synonyms: |
Mfn2M376V |
| Gene: |
Mfn2 Location: Chr4:147958056-147989161 bp, - strand Genetic Position: Chr4, 78.56 cM
|
| Alliance: |
Mfn2em3Gwd page
|
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Single point mutation
|
| |
|
Mutation details: CRISPR/Cas9 technology generated an A to G change resulting in a methionine to valine substitution at amino acid 376 (p.M376V) in exon 12. A synonymous mutation p.S378 (TCC to TCA) was also introduced to prevent the binding and recutting of the sequence by gRNA. This is a Charcot-Marie-Tooth disease type 2A-associated mutation.
(J:342938)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mfn2 Mutation: |
27 strains or lines available
|
|
| Original: |
J:342938 Franco A, et al., A human mitofusin 2 mutation can cause mitophagic cardiomyopathy. Elife. 2023 Nov 1;12 |
| All: |
1 reference(s) |
|